Nonerythrodermic, leukemic variant of cutaneous T-cell lymphoma with indolent clinical course: Th2-type tumor cells lacking T-cell receptor/CD3 expression and coinfiltrating tumoricidal CD8+ T cells

Journal of the American Academy of Dermatology

Volumn 43, Issue 5, 2000, Pages 946-954

  Tokura, Yoshiki ^a   Yagi, Hiroaki ^a   Seo, Naohiro ^a   Takagi, Tomoko ^a   Takigawa, Masahiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CANCER INFILTRATION; CASE REPORT; CLINICAL FEATURE; CYTOTOXICITY; DISEASE COURSE; ERYTHRODERMA; FEMALE; HUMAN; HUMAN TISSUE; PARAPSORIASIS; PRIORITY JOURNAL; SKIN MANIFESTATION; T CELL LYMPHOMA; T LYMPHOCYTE; TH2 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

AGED; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD8; BREAST; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTES; LYMPHOMA, T-CELL, CUTANEOUS; RECEPTORS, ANTIGEN, T-CELL; SKIN NEOPLASMS; TH2 CELLS;

EID: 0033763741     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2000.101880     Document Type: Article

References (28)

1. Cutaneous T-cell lymphoma: Mycosis fungoides, Sezary syndrome, and other variants
2. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins
3. + T cells: Comparative analysis of skin and blood in mycosis fungoides/Sezary syndrome relative to normal blood values
4. CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells
5. Aberrant cytokine production by Sezary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells
6. A new monoclonal antibody (CH-F42) recognizes a CD7- subset of normal T lymphocytes and circulating malignant cells in adult T-cell lymphomaleukemia and Sezary syndrome
7. CD7-positive Sezary syndrome with a Th1 cytokine profile
8. Lymphoma, pseudolymphoma and related conditions
9. Defective TCR surface expression associated with impaired TCR beta-chain assembly in a patient with cutaneous T-cell lymphoma
10. A unique phenotype of skin-associated lymphocytes in humans: Preferential expression of the HECA-452 epitope by benign and maliganant T cells at cutaneous sites
11. Low frequency of somatic mutation in b-chain variable region genes of human T-cell receptors
12. Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sezary syndrome: Its enhancement by interferon-gamma (IFN-γ) and IL-12 and fluctuations in association with disease activity
13. Lymphomatoid papulosis: Histologic and immunohistochemical studies in a patient with a scaly pigmented eruption
14. Cell-mediated cytotoxicity: A highly sensitive and informative flow cytometric assay
15. Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras
16. True T-cell chronic lymphocytic leukemia: A morphologic and immunophenotypic study of 25 cases
17. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
18. Primary cutaneous pleomorphic small T-cell lymphoma: A review of 11 cases
19. Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sezary syndrome
20. Skin-selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma
21. Familial defect in the surface expression of the T cell receptor-CD3 complex
22. Lymphocyte-epidermis interactions in malignant epidermotropic lymphomas: I, ultrastructural aspects
23. Demonstration of OKT 6-positive cells in mycosis fungoides
24. Role of Langerhans cells in epidermotropism of T cells
25. Cutaneous T-cell lymphoma with massive co-infiltration of polyclonal B cells
26. The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens
27. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: Successful treatment with recombinant interferon-γ
28. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes